Ying L. Liu

2.2k total citations
48 papers, 481 citations indexed

About

Ying L. Liu is a scholar working on Reproductive Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ying L. Liu has authored 48 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Reproductive Medicine, 19 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Ying L. Liu's work include Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Genetic factors in colorectal cancer (10 papers). Ying L. Liu is often cited by papers focused on Ovarian cancer diagnosis and treatment (22 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Genetic factors in colorectal cancer (10 papers). Ying L. Liu collaborates with scholars based in United States, China and United Kingdom. Ying L. Liu's co-authors include Dmitriy Zamarin, Eileen P. Connolly, Shing M. Lee, Anurag Saraf, Kevin Kalinsky, Britta Weigelt, Xiaobo Zhong, Carol Aghajanian, Hanina Hibshoosh and Jason Konner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Discovery.

In The Last Decade

Ying L. Liu

45 papers receiving 477 citations

Peers

Countries citing papers authored by Ying L. Liu

Since Specialization

Citations

This map shows the geographic impact of Ying L. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying L. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying L. Liu more than expected).

Fields of papers citing papers by Ying L. Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying L. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying L. Liu. The network helps show where Ying L. Liu may publish in the future.

Co-authorship network of co-authors of Ying L. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying L. Liu. A scholar is included among the top collaborators of Ying L. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying L. Liu. Ying L. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study 2025 ·Gynecologic Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kathleen M. Darcy, Chunqiao Tian, D.S. Kapp, Ying L. Liu, John K. C. Chan	0
2	Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy 2025 ·Journal of Hematology & Oncology ·Qin Hu, Yifei Zhu, Jie Mei, Ying L. Liu, (unknown)	17
3	Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer 2024 ·Cancer ·Mackenzie W. Sullivan, (unknown), (unknown), Qin Zhou, (unknown), Lora H. Ellenson, S. Dennis, Carol Aghajanian, Ying L. Liu, Yukio Sonoda, Roisin E. O’Cearbhaill, Britta Weigelt, Rachel N. Grisham	3
4	A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair‐deficient and microsatellite instability‐high endometrial cancers 2024 ·Cancer ·Ying L. Liu, Britta Weigelt	8
5	Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center 2024 ·Gynecologic Oncology ·Ying L. Liu, (unknown), Sarah Chiang, Kelly A. Devereaux, James Huang, Gabrielle Rizzuto, Duaa H. Al-Rawi, Britta Weigelt, (unknown), (unknown), Carol Aghajanian	1
6	Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification 2024 ·Gynecologic Oncology ·(unknown), Andrea Gazzo, Satshil Rana, (unknown), (unknown), Lora H. Ellenson, Ying L. Liu, Britta Weigelt, Amir Momeni Boroujeni	6
7	Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy 2023 ·Cancer Cell International ·Li Yang, Yang Liu, Keyan Yang, Ling Jin, H. J. Yang, Shuang Huang, Ying L. Liu, Bo Hu, Rong Liu, Wei Liu, Ansheng Liu, Qinlong Zheng, Yonghong Zhang	2
8	To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Ying L. Liu, Huanhuan Sha, Weiwei Peng, Rong Yin, Guoren Zhou, Ying Fang	11
9	Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications 2023 ·Cancer Discovery ·Britta Weigelt, Antonio Marra, Pier Selenica, Eric Rios‐Doria, Amir Momeni Boroujeni, Michael F. Berger, Kanika Arora, (unknown), Alexia Iasonos, Debyani Chakravarty, Nadeem R. Abu‐Rustum, Arnaud Da Cruz Paula, Kimberly Dessources, Lora H. Ellenson, Ying L. Liu, Carol Aghajanian, Carol L. Brown	19
10	Artificial Intelligence in Cervical Cancer Research and Applications 2023 ·Chunhui Liu, Jiahui Yang, Ying L. Liu, Ying Zhang, (unknown), (unknown), Chan Liu	3
11	Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study 2023 ·Gynecologic Oncology ·(unknown), Beryl Manning‐Geist, (unknown), Jessica A. Lavery, (unknown), (unknown), Alexia Iasonos, Yukio Sonoda, Rachel N. Grisham, Ying L. Liu, Vance Broach, Oliver Zivanovic, Kara Long Roche, Ginger J. Gardner, S. Dennis	1
12	Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management 2023 ·Gynecologic Oncology ·Ying L. Liu, Beryl Manning‐Geist, Andrea Knežević, Luxue Deng, (unknown), Samuel A. Funt, Jane Meisel, Oliver Zivanovic, Kara Long Roche, Yukio Sonoda, Ginger J. Gardner, Rachel N. Grisham, Roisin E. O’Cearbhaill, William P. Tew, Nadeem R. Abu‐Rustum, S. Dennis, Carol Aghajanian, Darren R. Feldman	4
13	GermlineSMARCA4Deletion as a Driver of Uterine Cancer: An Atypical Presentation 2022 ·JCO Precision Oncology ·(unknown), Duaa H. Al-Rawi, Vicky Makker, Britta Weigelt, Dmitriy Zamarin, Ying L. Liu, Angela G. Arnold, M. Herman Chui, Diana Mandelker, Michael F. Walsh, Deborah F. DeLair, Karen A. Cadoo, Roisin E. O’Cearbhaill	3
14	Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome 2022 ·Genetics in Medicine ·Ying L. Liu, Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo‐Mullen, (unknown), (unknown), (unknown), Robert A. Soslow, Ozge Ceyhan‐Birsoy, Diana Mandelker, Maria I. Carlo, Michael F. Walsh, Jinru Shia, Arnold J. Markowitz, Kenneth Offit, Zsofia K. Stadler, Alicia Latham	10
15	Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer 2021 ·npj Breast Cancer ·Ying L. Liu, Cecilie L. Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser, Ling Lu, Marta Vallee Cobham, Eleni Andreopoulou, Tessa Cigler, Anne Moore, (unknown), Veronica Fitzpatrick, Maureen M. Ward, J. David Warren, Claudia Fischbach, Vivek Mittal, Linda T. Vahdat	58
16	Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors 2021 ·npj Genomic Medicine ·Rena Elkin, Jung Hun Oh, Ying L. Liu, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho, Dmitriy Zamarin, Joseph O. Deasy, Larry Norton, Arnold J. Levine, Allen Tannenbaum	19
17	Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery 2019 ·Journal of Gynecologic Oncology ·Ying L. Liu, Olga T. Filippova, Qin Zhou, Alexia Iasonos, S. Dennis, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner, Vance Broach, Roisin E. O’Cearbhaill, Jason Konner, Carol Aghajanian, Kara Long Roche, William P. Tew	23
18	Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer 2019 ·Gynecologic Oncology ·Ying L. Liu, Qin Zhou, Alexia Iasonos, (unknown), Claire F. Friedman, Jason Konner, Roisin E. O’Cearbhaill, Carol Aghajanian, Dmitriy Zamarin	15
19	Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis 2017 ·Clinical Breast Cancer ·Ying L. Liu, Christine Choi, Shing M. Lee, Xiaobo Zhong, Hanina Hibshoosh, Kevin Kalinsky, Eileen P. Connolly	13
20	Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy 2016 ·Breast Cancer Research and Treatment ·Ying L. Liu, Anurag Saraf, Shing M. Lee, Xiaobo Zhong, Hanina Hibshoosh, Kevin Kalinsky, Eileen P. Connolly	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact